当前位置：
X-MOL 学术
›
Antimicrob. Agents Chemother.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Response to Yan and Muller “Single-Cell RNA Sequencing Supports Preferential Bioactivation of Remdesivir in the Liver”
Antimicrobial Agents and Chemotherapy ( IF 4.1 ) Pub Date : 2021-08-09 , DOI: 10.1128/aac.01394-21 Eisuke Murakami 1 , John Bilello 1 , Ruidong Li 1 , Li Li 1 , Danielle Porter 1 , Rita Humeniuk 1 , Richard Mackman 1 , Tomas Cihlar 1 , Anu Osinusi 1 , Joy Feng 1
Antimicrobial Agents and Chemotherapy ( IF 4.1 ) Pub Date : 2021-08-09 , DOI: 10.1128/aac.01394-21 Eisuke Murakami 1 , John Bilello 1 , Ruidong Li 1 , Li Li 1 , Danielle Porter 1 , Rita Humeniuk 1 , Richard Mackman 1 , Tomas Cihlar 1 , Anu Osinusi 1 , Joy Feng 1
Affiliation
In their commentary “Single-Cell RNA Sequencing Supports Preferential Bioactivation
of Remdesivir in the Liver”, Yan and Muller state that two key pieces of data were
misrepresented in our recent article titled “Key Metabolic Enzymes in Remdesivir ...
中文翻译：
对 Yan 和 Muller 的回应“单细胞 RNA 测序支持瑞德西韦在肝脏中的优先生物激活”
在他们的评论“Single-Cell RNA Sequencing Supports Preferential Bioactivation of Remdesivir in the Liver”中，Yan 和 Muller 指出，在我们最近题为“Remdesivir 中的关键代谢酶……
更新日期：2021-09-12
中文翻译：
对 Yan 和 Muller 的回应“单细胞 RNA 测序支持瑞德西韦在肝脏中的优先生物激活”
在他们的评论“Single-Cell RNA Sequencing Supports Preferential Bioactivation of Remdesivir in the Liver”中，Yan 和 Muller 指出，在我们最近题为“Remdesivir 中的关键代谢酶……
京公网安备 11010802027423号